Chimeric Antigen Receptor T (CAR-T) Cell Therapy

Chimeric Antigen Receptor T (CAR-T) Cell Therapy is a technique for engineering T cells, which are part of the immune system, to combat cancer.

  • White blood cells known as T cells combat invading invaders.
  • T cells from patients' blood are extracted and altered by inserting a gene for a synthetic receptor (called CAR).
  • CAR is a unique receptor that was developed in a lab and is intended to bind to particular proteins on cancer cells.
  • CAR is then added to T cells. This helps them better identify specific cancer cell antigens. These changed T cells called CAR- T cells.
  • CAR-T cells are then ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Buy May 2023 Issue

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Related Content

Science & Technology